Fidelis Capital Partners, LLC Boston Scientific Corp Transaction History
Fidelis Capital Partners, LLC
- $654 Billion
- Q1 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 13,839 shares of BSX stock, worth $1.09 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
13,839
Previous 13,036
6.16%
Holding current value
$1.09 Million
Previous $754 Million
46.44%
% of portfolio
0.06%
Previous 0.17%
Shares
6 transactions
Others Institutions Holding BSX
# of Institutions
1,347Shares Held
1.17BCall Options Held
5.99MPut Options Held
5.97M-
Vanguard Group Inc Valley Forge, PA127MShares$10 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY127MShares$9.97 Billion0.21% of portfolio
-
State Street Corp Boston, MA62.7MShares$4.93 Billion0.19% of portfolio
-
Massachusetts Financial Services CO Boston, MA46.6MShares$3.66 Billion0.99% of portfolio
-
Primecap Management CO Pasadena, CA37.9MShares$2.98 Billion1.97% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $113B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...